Lonza Group Ltd (LZAGY)
57.38
+0.74
(+1.31%)
USD |
OTCM |
May 03, 15:15
Lonza Group Market Cap: 41.38B for May 3, 2024
Market Cap Chart
Historical Market Cap Data
Date | Value |
---|---|
May 02, 2024 | 40.85B |
May 01, 2024 | 39.76B |
April 30, 2024 | 39.90B |
April 29, 2024 | 41.30B |
April 26, 2024 | 41.68B |
April 25, 2024 | 40.75B |
April 24, 2024 | 41.30B |
April 23, 2024 | 41.52B |
April 22, 2024 | 40.16B |
April 19, 2024 | 39.77B |
April 18, 2024 | 40.13B |
April 17, 2024 | 41.32B |
April 16, 2024 | 41.57B |
April 15, 2024 | 41.86B |
April 12, 2024 | 42.02B |
April 11, 2024 | 42.94B |
April 10, 2024 | 42.32B |
April 09, 2024 | 43.66B |
April 08, 2024 | 44.34B |
April 05, 2024 | 43.70B |
April 04, 2024 | 43.26B |
April 03, 2024 | 43.29B |
April 02, 2024 | 42.35B |
April 01, 2024 | 43.31B |
March 28, 2024 | 43.21B |
Date | Value |
---|---|
March 27, 2024 | 42.86B |
March 26, 2024 | 42.45B |
March 25, 2024 | 42.19B |
March 22, 2024 | 42.51B |
March 21, 2024 | 41.88B |
March 20, 2024 | 41.64B |
March 19, 2024 | 39.01B |
March 18, 2024 | 38.73B |
March 15, 2024 | 38.63B |
March 14, 2024 | 39.25B |
March 13, 2024 | 38.66B |
March 12, 2024 | 37.67B |
March 11, 2024 | 37.71B |
March 08, 2024 | 38.08B |
March 07, 2024 | 38.28B |
March 06, 2024 | 37.08B |
March 05, 2024 | 37.07B |
March 04, 2024 | 37.74B |
March 01, 2024 | 38.09B |
February 29, 2024 | 37.71B |
February 28, 2024 | 37.95B |
February 27, 2024 | 38.09B |
February 26, 2024 | 37.72B |
February 23, 2024 | 37.92B |
February 22, 2024 | 37.68B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
22.47B
Minimum
May 13 2019
63.43B
Maximum
Aug 27 2021
40.98B
Average
42.32B
Median
Market Cap Benchmarks
Roche Holding AG | 190.22B |
AC Immune SA | 234.39M |
CRISPR Therapeutics AG | 4.756B |
Addex Therapeutics Ltd | 9.192M |
NLS Pharmaceutics Ltd | 5.723M |
Market Cap Related Metrics
PE Ratio | 57.77 |
PS Ratio | 5.614 |
Price to Book Value | 3.677 |
Price | 57.38 |
Earnings Yield | 1.73% |
Operating PE Ratio | 43.34 |
Normalized PE Ratio | 57.55 |